Showing results for: Medical Diagnostics Articles & Analysis
-
Visby Medical to Present at the J.P. Morgan 40th Annual Healthcare Conference
Visby Medical™, a leading medical diagnostic company, today announced that it will make its debut appearance at the 40th Annual J.P. Morgan Healthcare Conference. Visby Founder and CEO Adam de la Zerda, PhD, will present virtually on Thursday, January 13, 2022, at 10:30 a.m. ET. During his presentation, de la Zerda will provide an overview of Visby’s latest developments in hand-held ...
-
Medical Diagnostic Kit
There is a huge gap between the state of the art of health care, which is available in urban areas and developed countries, and the kind of healthcare services available to the rural population in developing countries. Many people in poorer societies suffer because of unavailability of simple and standard medical facilities and diagnostics. Neurosynaptic Communications plans to bridge this gap ...
-
CeQur Appoints Peter B. Luther to Board of Directors
CeQur® announced the appointment of Peter B. Luther to its board of directors, effective immediately. Luther is a 29-year veteran of the medical device and diagnostics, OTC drugs and consumer-packaged goods industries. ...
-
Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan, thefirst and onlypatient-friendly preparation-freescreening test to detect polypsbeforethey may transform into colorectal cancer (CRC), today announced that the Company has received approval from the U.S. Food and Drug Administration ...
-
FDA submission for Emergency Use Authorisation
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that following completion of the of US performance studies, its technology partner, Mologic Ltd (“Mologic”) has filed its submission to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for its rapid point-of-care COVID-19 antigen ...
-
CPI Installs RTO at Medical Diagnostics Manufacturer
Catalytic Products International (CPI) recently installed a Regenerative Thermal Oxidizer (RTO) at a Midwest USA medical products manufacturer for the abatement of volatile organic compounds (VOC). The 10,000 SCFM TRITON-10.95 Regenerative Thermal Oxidizer (RTO) will control VOC emissions from a single strip coating line and tunnel dryer. In this application the exhaust stream contains solvents ...
-
BYTEC is 30
This year BYTEC Medizintechnik GmbH celebrates her 30-year-old existence. Dear business partners, We would like to thank you for your trust and the good cooperation and look forward to developing and producing many more innovative products for the medical, laboratory and diagnostics field together with you. Paul W. Coenen President and ...
-
Anavasi Diagnostics Announces Appointment of Scott Robitaille As Vice President Of Sales And Marketing
Anavasi Diagnostics ('Anavasi'), a medical technology company focused on the development of novel molecular diagnostic testing, has announced the addition of Scott Robitaille as Vice President of Sales & Marketing. Robitaille joins Anavasi with in-depth knowledge of the medical device and molecular diagnostics sector and over two decades of sales, marketing, and channel management ...
-
Check-Cap Ltd. (NASDAQ: CHEK) Announces Receipt of Extension to Meet the Nasdaq`s Minimum Bid Price Requirement
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colorectal cancer (CRC), announces that onJune 22, 2022, it received a letter from The Nasdaq Stock Market LLC ...
-
Bluejay Reports FDA Agrees to Consider its Plan to Pursue a De Novo Regulatory Pathway for the Symphony IL-6 Test
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”, “the Company”), a medical diagnostics company focused on developing cost-effective, rapid, near-patient products for triage and monitoring of disease progression, today announced that the FDA has agreed to consider Bluejay’s plan to pursue a De Novo submission for the Symphony IL-6 Test. In written feedback to the ...
-
Criticality of STAT Osmolality Testing: Identifying Toxic Alcohol Ingestion, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn what osmolality testing is and how it can be used, the difference between calculated and measured osmolality and the significance of the osmolar gap in diagnosing toxic alcohols such as ethylene glycol. Attendees will understand why timely osmolality measurements are critical for informing prompt treatment in cases of toxic alcohol ingestion. The featured speakers will ...
-
Christie Med Announces New Authorized Partner in Al Zahrawi for UAE Distribution of VeinViewer
As the leader in vein visualization technology throughout the world, Christie’s high-quality, made-in-the-USA, VeinViewer® Vision2 and VeinViewer® Flex, continue to provide customers with improved clinical outcomes such as increasing 1st stick success, decreasing medically not required PICC lines and enhancing patient satisfaction. We are committed to the continued growth of ...
-
Famed American Geneticist, George Church, Joins Alveo’s Scientific Advisory Board
We are pleased to announce that famed American Geneticist George Church will be joining Alveo’s Scientific Advisory Board. With extensive background in medical diagnostics, including founding application-based companies, George will bring valuable expertise to our Board as we continue to grow and democratize our healthcare system. “At Alveo, we are focused on intercepting the spread ...
-
Moray Medical named a Rosenman Innovator
An esteemed panel of subject matter experts, clinicians, and investors selected Moray Medical (then called Project Moray) as a Rosenman Innovator for its innovative technology and patient impact, digitizing the user interface of cardiac catheter systems to enable precise delivery of therapies within the beating hearts of millions of patients. The UCSF Rosenman Institute, a health technology ...
-
Biotricity CEO, Waqaas Al-Siddiq, to participate in panel discussion on the evolution of medical devices at the American Medical Device Summit on October 19th
Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that Waqaas Al-Siddiq, Founder and CEO, is scheduled to participate in a panel discussion at the American Medical Device Summit on October 19, 2022 in Chicago, Illinois. American Medical Device Summit: Location: Westin Chicago ...
-
Kim D. Blickenstaff Joins RMI Board of Directors as an Observer
“We are delighted to have Kim on the team”, said Laura Piccinini CEO of RMI. “He brings tremendous wisdom and experience building successful medical device companies.” Mr. Blickenstaff has served as the Chairman of the board of directors of Tandem Diabetes ($5.23 billion market cap) since March 2020. Mr. Blickenstaff previously served as Executive Chairman of the board ...
-
Noleus Wins Audience Choice at MedTech Innovator Pitch Event
Noleus Technologies won the audience choice award at the MedTech Innovator Houston Pitch Event. The event was hosted at the Johnson and Johnson Innovation JLABS@TMC event space. According to the MedTech Innovator website, these events "feature pitches from best-in-class medical device, diagnostic, and digital health companies vying for a spot in the 2018 program." Judging from local experts in ...
-
PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a diversified commercial-stage medical technology company, and its majority-owned subsidiary Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”), a commercial-stage cancer prevention medical diagnostics company, today announced that PAVmed and Lucid Chairman & Chief Executive Officer Lishan Aklog, M.D. was selected as one of ...
By PAVmed Inc.
-
Cytovale Secures Additional BARDA Funding for 10-Minute IntelliSep Test for Sepsis
Cytovale, a medical diagnostics company focused on providing rapid and insightful tools to improve early detection of fast-moving and immune-mediated diseases, has received additional funding from Biomedical Research and Development Authority (BARDA) to help advance the company’s 10-minute IntelliSep sepsis risk stratification test towards commercial launch. This latest contract action, ...
-
The Centers for Medicare and Medicaid (CMS) announced the MCIT pathway to provide national Medicare coverage for FDA Breakthrough Devices and Diagnostic
The Centers for Medicaid and Medicare (CMS) announced the establishment of the MCIT (Medicare Coverage of Innovative Technology) pathway, which is designed to provide coverage and access to new, innovative medical devices and diagnostics which have received FDA Breakthrough Device Designation to Medicare beneficiaries nationwide. Through this pathway, Breakthrough devices will automatically be ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you